Small biotech Omeros on Monday reported some early success in a small test of its coronavirus treatment and OMER stock soared.
In the test of six patients severely ill with Covid-19 in Bergamo, Italy, all recovered, Omeros said. The "compassionate-use study" evaluated Omeros' narsoplimab.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,